Design, synthesis, and evaluation of orally active fibrinogen inhibitors

Design, synthesis, and evaluation of orally active fibrinogen inhibitors Design, synthesis, and evaluation of fibrinogen inhibitors, ω-(p-amidinophenoxy) alkanoylaspartic acid derivatives Tetrafibricin: A nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I) its GPIIB/IIIA blockage on solid phase binding assay Inhibition of Plasminogen Activator Inhibitor-1 Activity by Two Diketopiperazines, XR330 and XR334 Produced by Streptomyces sp. Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis New fibrinolytic agents: benzothiophene derivatives as inhibitors of the t-PA–PAI-1 complex formation Design and Synthesis of Potent and Highly Selective Thrombin Inhibitors FR-900452, a specific antagonist of platelet activating factor (PAF) produced by Streptomyces phaeofaciens. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics. Tetrahydrothienopyridine derivatives as novel GPIIb/IIIa antagonists Tetrafibricin, a novel fibrinogen receptor antagonist. I. Taxonomy, fermentation, isolation, characterization and biological activities.